Kure Advisory’s Johnson & Johnson JNJ Stock Holding History

Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake
Trade Value Portfolio Weight Portfolio Position
2026
Q1
$223K Sell
913
-184
-17% -$42.9K 0.12% 51
2025
Q4
$227K Buy
+1,097
New +$217K 0.13% 50
2024
Q1
Sell
-2,752
Closed -$431K 82
2023
Q4
$431K Buy
2,752
+141
+5% +$21.6K 0.22% 55
2023
Q3
$407K Buy
+2,611
New +$431K 0.23% 56

Other funds holding JNJ

Kure Advisory's JNJ Position: Q1 2026 in Review

Kure Advisory reduced its Johnson & Johnson (JNJ) stake by 17% in Q1 2026, selling an estimated $42.9K and leaving 913 shares worth $223K. The position accounts for 0.12% of the portfolio, ranked #51.

Kure Advisory first reported a position in JNJ in Q3 2023 and has held it in 4 quarters since. The position peaked at $431K in Q4 2023. 4,613 funds tracked by Wall St. Rank hold JNJ as of Q1 2026.

  • Kure Advisory held 913 shares of Johnson & Johnson worth $223K as of Q1 2026.
  • Kure Advisory sold 184 Johnson & Johnson shares in Q1 2026, an estimated $42.9K.
  • Johnson & Johnson made up 0.12% of Kure Advisory's portfolio in Q1 2026, its #51 holding.
  • Kure Advisory first reported a position in Johnson & Johnson in Q3 2023 and has held it in 4 quarters since.
  • Kure Advisory's Johnson & Johnson position peaked at $431K in Q4 2023.
  • 4,613 funds tracked by Wall St. Rank held Johnson & Johnson as of Q1 2026.

Based on Kure Advisory's 13F filing for Q1 2026, filed 17 Apr 2026.